Just weeks after Alere Inc. agreed to produce documents related to three government probes of its business, Abbott Laboratories said it has filed suit in the Delaware Court of Chancery seeking to terminate its $5.8 billion purchase of the health care diagnostics company.

Abbott announced the complaint on Wednesday, citing “substantial loss” to Alere’s value in the 10 months since the companies agreed to merge in January 2016.